Humana Inc (NYSE:HUM) hired Goldman Sachs Group Inc (NYSE:GS) to explore and provide advice on the potential sale of its urgent care unit Concentra, according to Reuters based on information obtained from people familiar with the situation.
Humana considers $1 billion value for Concentra
According to the sources, Humana Inc (NYSE;HUM) is considering to value Concentra for approximately $1 billion. The healthcare company is exploring a sale for its urgent care unit four years after acquiring it.
Industry observers suggest that the move of Human Inc (NYSE:HUM) is an indication that it is facing challenges operating healthcare centers by itself in order to better manage medical costs.
Humana Inc (NYSE:HUM) is one of the largest providers of Medicare plans for the elderly in the United States. The company operated three business segments including retail, employer group and health & well-being services.
Humana Inc (NYSE:HUM) hired Goldman Sachs Group Inc (NYSE:GS) declined to comment about the report. The sources requested Reuters not to disclose their identity because of the private nature of the issue.
Humana signs agreement with Via Christi Health
Separately, Humana Inc (NYSE:HUM) entered a new Accountable Care agreement with Via Christi Health. According to the company, the main objective of the agreement is to improve the health and provide more coordinated services for its Humana Medicare Advantage members.
In a statement, Kathleen Faulk, Humana’s regional president for senior markets in Kansas said, “Accountable care relationships are a critical step in creating a system that creates health and works together in a more coordinated way. With their tremendous scope of services and highly integrated model, Via Christi is an ideal partner as we continue to create a better health care experience for our members.”
The new Accountable Care agreement between Humana Inc (NYSE:HUM) and Via Christi include pay-for-results incentives based on improved clinical outcomes, better patient experience and reduced costs.
Humana Inc (NYSE:HUM) said the value-based arrangement provides emphasis on quality outcomes with a focus on care coordination and leverages measures as defined by the National Committee for Quality Assurance (NCQA) and Healthcare Effectiveness Data and Information Set (HEDIS) such as diabetes care and treatment, breast cancer screenings, colorectal cancer screenings and high-risk medication.
